Deferred Federal Income Tax Expense (Benefit) in USD of Biofrontera Inc. from Q2 2021 to 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Biofrontera Inc. quarterly/annual Deferred Federal Income Tax Expense (Benefit) history and change rate from Q2 2021 to 2024.
- Biofrontera Inc. Deferred Federal Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
- Biofrontera Inc. Deferred Federal Income Tax Expense (Benefit) for the twelve months ending March 31, 2023 was $0.000.
- Biofrontera Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2024 was $0.000.
- Biofrontera Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2023 was $0.000.
Deferred Federal Income Tax Expense (Benefit), Trailing 12 Months (USD)
Deferred Federal Income Tax Expense (Benefit), Quarterly (USD)
Deferred Federal Income Tax Expense (Benefit), Annual (USD)